Catalyst Pharmaceuticals Inc (CPRX)

10:36 AM

ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M - TradingView

10:36 AM

09:40 AM

Are Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now? - Yahoo Finance

09:40 AM

09:03 AM

Best Value Stocks to Buy for March 4th - Yahoo Finance Singapore

09:03 AM

Mar 03, 2026

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Uncovering a 41% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat

Mar 03, 2026

Mar 03, 2026

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Vanguard Group Inc. - MarketBeat

Mar 03, 2026

Mar 02, 2026

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Mar 02, 2026

Mar 02, 2026

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mar 02, 2026

Mar 01, 2026

Catalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Royce & Associates LP - MarketBeat

Mar 01, 2026

Mar 01, 2026

Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results - Insider Monkey

Mar 01, 2026

Feb 28, 2026

Why Catalyst Pharmaceuticals (CPRX) Is Down 5.0% After Issuing 2026 Guidance And Buyback PlanAnd What's Next - Sahm

Feb 28, 2026

Feb 27, 2026

CPRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 27, 2026

Feb 27, 2026

Catalyst Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Feb 27, 2026

Feb 26, 2026

Catalyst Pharmaceuticals Inc (CPRX) Q4 2025 Earnings Call Highli - GuruFocus

Feb 26, 2026

Feb 26, 2026

Catalyst Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026

Feb 26, 2026

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y - Finviz

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: Catalyst Pharmaceuticals Q4 2025 earnings beat expectations By Investing.com - Investing.com South Africa

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: Catalyst Pharmaceuticals Q4 2025 earnings beat expectations - Investing.com India

Feb 26, 2026

Feb 26, 2026

Catalyst Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Catalyst Pharma Q4 Net Income Slips; Announces FY26 Outlook - Nasdaq

Feb 26, 2026

Feb 26, 2026

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Shows Technical Setup for Potential Breakout - ChartMill

Feb 26, 2026

Feb 26, 2026

Catalyst Pharmaceuticals (CPRX) Net Margin Strength Reinforces Bullish Earnings Narrative - Sahm

Feb 26, 2026

Feb 26, 2026

Decoding Catalyst Pharmaceuticals Inc (CPRX): A Strategic SWOT I - GuruFocus

Feb 26, 2026

Feb 25, 2026

Catalyst Pharmaceuticals (NASDAQ:CPRX) Releases Quarterly Earnings Results, Beats Expectations By $0.26 EPS - MarketBeat

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals Q4 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Catalyst Pharma Posts Record 2025 Results, Raises 2026 Outlook - TipRanks

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals (CPRX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Feb 25, 2026

Feb 25, 2026

Earnings Flash (CPRX) Catalyst Pharmaceuticals Posts Q4 Revenue $152.6M, vs. FactSet Est of $142.7M - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Earnings Flash (CPRX) Catalyst Pharmaceuticals Posts Q4 Adjusted EPS $0.68, vs. FactSet Est of $0.59 - marketscreener.com

Feb 25, 2026

Feb 25, 2026

CPRX | Catalyst Pharmaceutical Inc. FinancialsIncome Statement - Quiver Quantitative

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance - The Manila Times

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals Reports Record Fourth Quarter and - GlobeNewswire

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals earnings on deck amid growth questions - Investing.com Nigeria

Feb 25, 2026

Feb 25, 2026

Catalyst Pharmaceuticals earnings on deck amid growth questions By Investing.com - Investing.com Canada

Feb 25, 2026

Feb 25, 2026

Catalyst: Q4 Financial Results Overview - Bitget

Feb 25, 2026

Feb 24, 2026

Catalyst Pharmaceuticals, Inc. (CPRX): Strong Buy Ratings and 43% Potential Upside Propel Investor Interest - DirectorsTalk Interviews

Feb 24, 2026

Feb 24, 2026

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock - Yahoo Finance

Feb 24, 2026

Feb 24, 2026

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference - The Manila Times

Feb 24, 2026

Feb 24, 2026

Aug Volume: Is Catalyst Pharmaceuticals Inc a defensive stockAnalyst Upgrade & Verified Chart Pattern Signals - baoquankhu1.vn

Feb 24, 2026

Feb 23, 2026

Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Feb 23, 2026

Feb 22, 2026

Jupiter Asset Management Ltd. Sells 116,575 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Feb 22, 2026

Feb 21, 2026

CEO Change: Is Catalyst Pharmaceuticals Inc a top pick in the sectorQuarterly Market Review & Safe Capital Preservation Plans - baoquankhu1.vn

Feb 21, 2026

Feb 20, 2026

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Skandinaviska Enskilda Banken AB publ - MarketBeat

Feb 20, 2026

Feb 20, 2026

Aberdeen Group plc Has $12.46 Million Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Feb 20, 2026

Feb 19, 2026

Catalyst Pharma (CPRX) HR chief receives stock from RSU vesting - Stock Titan

Feb 19, 2026

Feb 19, 2026

Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs (CPRX) - Seeking Alpha

Feb 19, 2026

Feb 19, 2026

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy? - Finviz

Feb 19, 2026

Feb 19, 2026

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

Feb 19, 2026

Feb 18, 2026

Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for - Finviz

Feb 18, 2026

Feb 18, 2026

Catalyst Pharmaceuticals (CPRX) Expected to Announce Earnings on Wednesday - MarketBeat

Feb 18, 2026

Feb 17, 2026

Catalyst Pharmaceuticals (CPRX) Stock Analysis: 42% Upside Potential Ignites Investor Interest - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

Public Sector Pension Investment Board Grows Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat

Feb 17, 2026

Feb 16, 2026

Aug Retail: Is Catalyst Pharmaceuticals Inc a momentum stock2025 Retail Activity & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Feb 16, 2026

Feb 15, 2026

Is Catalyst Pharmaceuticals Inc.’s growth already priced inTrade Exit Summary & Fast Gain Stock Trading Tips - mfd.ru

Feb 15, 2026

Feb 15, 2026

Is Catalyst Pharmaceuticals Inc. stock attractive for hedge fundsJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - mfd.ru

Feb 15, 2026

Feb 14, 2026

What is Catalyst Pharmaceuticals Inc. s 5 year growth outlookQuarterly Profit Report & Weekly Setup with High ROI Potential - mfd.ru

Feb 14, 2026

Feb 14, 2026

Will Catalyst Pharmaceuticals Inc. benefit from government policy2025 Sector Review & High Accuracy Swing Entry Alerts - mfd.ru

Feb 14, 2026

Feb 12, 2026

Block Trades: Is iShares Gold Trust impacted by rising ratesInflation Watch & Community Consensus Trade Alerts - baoquankhu1.vn

Feb 12, 2026

Feb 11, 2026

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - GlobeNewswire

Feb 11, 2026

Feb 11, 2026

Catalyst Pharmaceuticals (CPRX) Investor Outlook: A Promising 41.4% Upside Potential - DirectorsTalk Interviews

Feb 11, 2026